Illumina to Submit Cytogenetics Package to FDA, Commits to Using Arrays in Dx | GenomeWeb

This story has been updated from a previous version. Illumina has submitted an undisclosed genetic test with its BeadXpress system to the FDA, not a PGx panel as previously reported.

By Justin Petrone

Marking a shift in strategy, Illumina plans to submit its iScan system and accompanying arrays and software to the US Food and Drug Administration for clearance, according to a company official.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.